Clinical applications of gene expression in colorectal cancer

Journal of Gastrointestinal Oncology

Volumn 4, Issue 2, 2013, Pages 144-157

  Kheirelseid, Elrasheid A H ^a   Miller, Nicola ^a   Chang, Kah Hoong ^a   Nugent, Mary ^a   Kerin, Michael J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Gene expression in colorectal cancer; Molecular profiling in colorectal cancer; Neoadjuvant chemoradiation therapy in rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; INTERLEUKIN 8; MEMBRANE PROTEIN; MUCIN 2; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADJUVANT CHEMORADIOTHERAPY; AGED; ARTICLE; CADHERIN 17 GENE; CANCER GRADING; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5 GENE; CHEMOKINE CXCL12 GENE; CHEMOKINE CXCR4 GENE; CHEMOKINE CXCR7 GENE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID BINDING PROTEIN 1 LIVER GENE; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERLEUKIN 8 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCIN2 GENE; PROGRAMMED CELL DEATH 4 GENE; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA 1 GENE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE 1 GENE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE 2 GENE; TUMOR INVASION; TUMOR VOLUME; UPREGULATION;

EID: 84995757535     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2013.010     Document Type: Article

References (51)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Comber H, Walsh PM. Patterns of care and survival of cancer patients in Ireland 1994 to 2004. Summary report. National Cancer Registry. Cork, Ireland,2008.
3. Forrester K, Almoguera C, Han K, et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
4. Cui H, Horon IL, Ohlsson R, et al. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998;4:1276-80.
5. Chan SK, Griffith OL, Tai IT, et al. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 2008;17:543-52.
6. Nannini M, Pantaleo MA, Maleddu A, et al. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 2009;35:201-9.
7. Birkenkamp-Demtroder K, Olesen SH, Sørensen FB, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005;54:374-84.
8. Varghese S, Burness M, Xu H, et al. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol 2007;14:3460-71.
9. Wang Y, Jatkoe T, Zhang Y, et al. Gene expression profiles and molecular markers to predict recurrence of Dukes, B colon cancer. J Clin Oncol 2004;22:1564-71.
10. Xu D, Li XF, Zheng S, et al. Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B 2006;7:445-51.
11. Iinuma H, Okinaga K, Egami H, et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 2006;28:297-306.
12. Ki DH, Jeung HC, Park CH, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 2007;121:2005-12.
13. Kollmar O, Rupertus K, Scheuer C, et al. CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1. Int J Cancer 2010;126:1302-15.
14. Ingold B, Schulz S, Budczies J, et al. The role of vascular CXCR4 expression in colorectal carcinoma. Histopathology 2009;55:576-86.
15. Meijer J, Ogink J, Roos E. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo. Br J Cancer 2008;99:1493-501.
16. Birkenkamp-Demtroder K, Christensen LL, Olesen SH, et al. Gene expression in colorectal cancer. Cancer Res 2002;62:4352-63.
17. Grade M, Hörmann P, Becker S, et al. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 2007;67:41-56.
18. Pei H, Zhu H, Zeng S, et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 2007;6:2495-501.
19. Kitahara O, Furukawa Y, Tanaka T, et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 2001;61:3544-9.
20. Barrier A, Lemoine A, Boelle PY, et al. Colon cancer prognosis prediction by gene expression profiling. Oncogene 2005;24:6155-64.
21. Colliver DW, Crawford NP, Eichenberger MR, et al. Molecular profiling of ulcerative colitis-associated neoplastic progression. Exp Mol Pathol 2006;80:1-10.
22. Friederichs J, Rosenberg R, Mages J, et al. Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int J Colorectal Dis 2005;20:391-402.
23. Lin YM, Furukawa Y, Tsunoda T, et al. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 2002;21:4120-8.
24. Bianchini M, Levy E, Zucchini C, et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol 2006;29:83-94.
25. Kim IJ, Lim SB, Kang HC, et al. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 2007;50:1342-53.
26. Xu WQ, Jiang XC, Zheng L, et al. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma. Exp Mol Pathol 2007;82:284-91.
27. Xu Y, Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007;16:R14-20.
28. Saltzman BS, Yamamoto JF, Decker R, et al. Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia. Cancer Res 2008;68:1236-44.
29. Skoglund Lundin J, Vandrovcova J, Song B, et al. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 2009;100:1674-9.
30. Zeng Q, Phukan S, Xu Y, et al. Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Res 2009;69:678-86.
31. Biswas S, Trobridge P, Romero-Gallo J, et al. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. Genes Chromosomes Cancer 2008;47:95-106.
32. Davoren PA, McNeill RE, Lowery AJ, et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 2008;9:76.
33. Kheirelseid EA, Chang KH, Newell J, et al. Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer. BMC Mol Biol 2010;11:12.
34. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
35. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
36. Cancer Projections 2005-2035. National Cancer Registry. 2008: Cork, Ireland.
37. Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
38. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
39. Sierro F, Biben C, Martínez-Muñoz L, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A 2007;104:14759-64.
40. Daniel P, Wagrowska-Danilewicz M, Danilewicz M, et al. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. Int J Colorectal Dis 2007;22:1165-72.
41. Matsushita M, Matsuzaki K, Date M, et al. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer 1999;80:194-205.
42. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779-88.
43. Hinoi T, Lucas PC, Kuick R, et al. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 2002;123:1565-77.
44. Takamura M, Ichida T, Matsuda Y, et al. Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma. Cancer Lett 2004;212:253-9.
45. Kwak JM, Min BW, Lee JH, et al. The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Dis Colon Rectum 2007;50:1873-80.
46. Lee S, Bang S, Song K, et al. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 2006;16:747-54.
47. Lawrie LC, Dundas SR, Curran S, et al. Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 2004;90:1955-60.
48. Yamazaki T, Kanda T, Sakai Y, et al. Liver fatty acid-binding protein is a new prognostic factor for hepatic resection of colorectal cancer metastases. J Surg Oncol 1999;72:83-7.
49. Mudduluru G, Medved F, Grobholz R, et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 2007;110:1697-707.
50. Göke R, Barth P, Schmidt A, et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 2004;287:C1541-6.
51. Silliman RA, Guadagnoli E, Rakowski W, et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 2002;20:2680-8.